SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as investors react to the CMS finalizing a Medicare Advantage rate increase for 2027 that arrived higher than previous projections. The community remains divided between those viewing the news as a bullish recovery catalyst that creates a short squeeze, and others who remain skeptical of the long-term regulatory headwinds and ongoing sector volatility.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as investors react to its strategic supply chain partnerships and the official disclosure of major hyperscaler collaborations that reinforce its critical role in AI infrastructure. The community is actively debating the stock's resilience amid broader semiconductor volatility, with many analyzing the disconnect between its strong fundamental outlook and recent price pressure.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is seeing intense volatility and scrutiny as investors weigh its Medicare Advantage exposure against proposed regulatory changes and looming quarterly earnings. The community is sharply divided, with some traders actively betting on a potential bounce or M&A activity, while others are cautioning against the stock's multi-year lows and ongoing policy-driven headwinds.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

The community is heavily focused on Wendy's as a potential buyout candidate and a high-yield dividend play, with significant discussion surrounding unusual short interest and expectations for a major leadership announcement. Traders are actively debating whether the stock's current valuation represents a deep-value opportunity or a long-term trap, while many look toward potential M&A activity and international expansion to serve as catalysts for a rally.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending due to heightened retail and institutional interest surrounding speculative manufacturing partnerships and potential integration into next-generation AR and wearable devices, despite ongoing investor concerns regarding the company's ability to scale production and hit near-term commercial targets. The community remains deeply divided, with bulls pointing to the company's significant cash reserves and strategic long-term roadmap, while bears emphasize the lack of material purchase orders and the persistent difficulty in maintaining stable manufacturing yields.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is currently seeing heightened investor interest as the community weighs strong GAAP profitability and a growing roster of Tier 1 banking partnerships against broader fintech sector volatility. Investors are actively discussing the stock's potential for a significant re-rating, debating whether recent price action is driven by macro-sensitive algorithmic trading or represents a long-term value opportunity for those betting on the company's AI-powered lending infrastructure.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as the market reacts to the Centers for Medicare and Medicaid Services (CMS) finalizing a Medicare Advantage payment policy that reflects a higher-than-feared 2.48% increase for 2027. Investors are actively discussing this outcome as a significant relief catalyst, shifting the focus from previous concerns about margin pressure and regulatory squeeze toward a potential repricing of earnings risk for the managed care sector.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is generating significant community buzz as participants debate its longevity, with many highlighting its history dating back to 2011 as evidence that it transcends typical short-term market trends. Supporters are actively positioning it as a cultural phenomenon and a long-term play, frequently drawing comparisons to major established assets while navigating discussions around its official contract address.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing intense market volatility as traders debate the sustainability of its financial position, characterized by significant debt levels and aggressive short-squeeze dynamics. The stock remains a heavily contested battleground, with the community split between those betting on a fundamental turnaround and others warning of potential exhaustion following recent parabolic price swings.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is capturing significant investor attention ahead of its quarterly results, with the community actively debating whether the stock's recent price compression is a long-term entry point or a reflection of underlying operational risks. While some retail traders are betting on a recovery fueled by strong membership growth and management's focus on AI-driven efficiency, others remain skeptical, pointing to recurring earnings misses and volatility in the health insurance sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regeneron Wins FDA Nod for Extended Eylea HD Dosing Interval

REGN wins FDA nod to extend Eylea HD dosing to 20 weeks, boosting flexibility for wAMD and DME patients while reinforcing its push to offset declining Eylea sales.

Aberdeen Group plc Buys 86,314 Shares of Sanofi $SNY

Aberdeen Group plc lifted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 22.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The...

Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease

SNY secures EU conditional approval for Rezurock to treat chronic GVHD in adults and children aged 12 years and older.

AZN Stock Gains as COPD Drug Clears Two Late-Stage Studies

AstraZeneca jumps as tozorakimab hits primary goals in two phase III COPD trials, cuts exacerbations and shows promise in a disease with limited options.

Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic Dermatitis

(RTTNews) - Sanofi SA (SNY, SNYNF,SAN.PA) announced encouraging results from three Phase 3 clinical trialsCOAST 1, COAST 2, and SHOREevaluating amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L). The studies, present...

Dynamic Advisor Solutions LLC Decreases Stock Holdings in Sanofi $SNY

Dynamic Advisor Solutions LLC reduced its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 87.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,290 shares of the company's stock after selling 52,401 shares du...

Top Research Reports for Palantir, Linde and Arista Networks

Today's Research Daily features new research reports on 16 major stocks, including Palantir Technologies Inc. (PLTR), Linde plc (LIN) and Arista Networks, Inc. (ANET), as well as two micro-cap stocks, Comstock Holding Companies, Inc. (CHCI) and United Bancorp, Inc. (UBCP).

Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up

DNLI surges after FDA approves Avlayah, its first commercial drug and a breakthrough Hunter syndrome therapy targeting the brain.

REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?

Regeneron's rally reflects biotech momentum as pipeline wins and Dupixent growth offset Eylea erosion amid intensifying competition.

<ul class="summary-bullets"><li>The bill proposes a pilot program in 10 states, allowing uninsured patients to access insulin at a capped price.</li><li>The bill also encourages lower list prices and increasing competition from generic and biosimilar options.</li><li>It aims to reform pharmacy benefit manager rebate systems, though funding details are not yet finalized.</li></ul>A bipartisan group of U.S. senators has reportedly reached a breakthrough deal to cap insulin prices at $35, aiming to ease the financial burden for millions living with diabetes.The proposal, led by Jeanne Shaheen and Susan Collins, now needs the backing of Senate Majority Leader John Thune and the approval of President Donald Trump, according to a Semafor <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.semafor.com/article/03/24/2026/senators-reach-deal-on-capping-insulin-costs-at-35">report</a> on Wednesday.<h2 class="st-heading-2">Bill Proposes Pilot Program In 10 States</h2>The plan initially focused on insured patients, while senators John Kennedy and Raphael Warnock pushed to include uninsured individuals. As a compromise, the bill proposes a pilot program in 10 states allowing uninsured patients to access insulin at a capped price.“I would really like to be able to leave the Senate thinking that we had helped to address insulin costs for a lot of Americans. This is the most expensive chronic disease,” Shaheen told Semafor.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cdc.gov/diabetes/php/data-research/index.html">report</a> by the Centers for Disease Control and Prevention in January, nearly 30 million Americans have been diagnosed with diabetes.&nbsp;&nbsp;The legislation also aims to cut costs by reforming pharmacy benefit manager rebate systems, though funding details are still being finalized.<h2 class="st-heading-2">Details Of The Proposal</h2>The bipartisan bill aims to lower insulin costs and expand access for patients. The bill would extend the $35 out-of-pocket cap, currently available to Medicare users, to those with private insurance.It also targets high insulin prices by encouraging lower list prices and increasing competition from generic and biosimilar options. In addition, the legislation ensures patients benefit directly from rebates and discounts typically handled by pharmacy benefit managers, helping reduce overall costs.Meanwhile, shares of top insulin producers traded mixed on Wednesday. Sanofi (SNY) stock was up 2%, while shares of Eli Lilly (LLY) gained 1.5%. Novo Nordisk (NVO) shares were down 1%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A woman holds an insulin pen with an exposed injection needle. Photo: Hannes P. Albert/dpa (Photo by Hannes P Albert/picture alliance via Getty Images)

Bipartisan US Senators Reportedly Reach Breakthrough To Cap Insulin Prices at $35 – SNY, LLY, NVO Stocks Gain Pre-Market

The proposal needs the backing of Senate Majority Leader John Thune and the approval of President Donald Trump, the report added.

Equity

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

SNY
Sanofi-Aventis

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SNY News

SNYSanofi-Aventis